Amgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference
Executives from Amgen (NASDAQ:AMGN) highlighted broad-based commercial growth, a set of six key growth drivers, and several late-stage pipeline programs during a conference session hosted by Leerink...